1. Home
  2. PULM vs EDRY Comparison

PULM vs EDRY Comparison

Compare PULM & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • EDRY
  • Stock Information
  • Founded
  • PULM 2003
  • EDRY 2018
  • Country
  • PULM United States
  • EDRY Greece
  • Employees
  • PULM N/A
  • EDRY N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • EDRY Marine Transportation
  • Sector
  • PULM Health Care
  • EDRY Consumer Discretionary
  • Exchange
  • PULM Nasdaq
  • EDRY Nasdaq
  • Market Cap
  • PULM 33.2M
  • EDRY 27.3M
  • IPO Year
  • PULM N/A
  • EDRY N/A
  • Fundamental
  • Price
  • PULM $5.62
  • EDRY $10.79
  • Analyst Decision
  • PULM
  • EDRY
  • Analyst Count
  • PULM 0
  • EDRY 0
  • Target Price
  • PULM N/A
  • EDRY N/A
  • AVG Volume (30 Days)
  • PULM 11.2K
  • EDRY 3.8K
  • Earning Date
  • PULM 08-12-2025
  • EDRY 08-07-2025
  • Dividend Yield
  • PULM N/A
  • EDRY N/A
  • EPS Growth
  • PULM N/A
  • EDRY N/A
  • EPS
  • PULM N/A
  • EDRY N/A
  • Revenue
  • PULM $1,921,000.00
  • EDRY $55,867,583.00
  • Revenue This Year
  • PULM N/A
  • EDRY N/A
  • Revenue Next Year
  • PULM $134.88
  • EDRY $28.27
  • P/E Ratio
  • PULM N/A
  • EDRY N/A
  • Revenue Growth
  • PULM N/A
  • EDRY 10.25
  • 52 Week Low
  • PULM $1.78
  • EDRY $7.60
  • 52 Week High
  • PULM $10.40
  • EDRY $23.28
  • Technical
  • Relative Strength Index (RSI)
  • PULM 32.49
  • EDRY 66.83
  • Support Level
  • PULM $5.60
  • EDRY $10.56
  • Resistance Level
  • PULM $6.15
  • EDRY $10.99
  • Average True Range (ATR)
  • PULM 0.28
  • EDRY 0.41
  • MACD
  • PULM -0.05
  • EDRY 0.05
  • Stochastic Oscillator
  • PULM 1.63
  • EDRY 79.38

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

Share on Social Networks: